Active ingredient
Semaglutide NDC Codes
Semaglutide is an active ingredient in 24 finished products listed with the FDA, under 3 names.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Strengths
- Semaglutide 4 mg/1; Semaglutide 9 mg/1; Semaglutide 1.5 mg/1; Semaglutide .68 mg/mL; Semaglutide 2.68 mg/mL; Semaglutide .25 mg/.5mL; Semaglutide 1.34 mg/mL; Semaglutide 25 mg/1; Semaglutide 1 mg/.5mL; Semaglutide .5 mg/.5mL; Semaglutide 2.4 mg/.75mL; Semaglutide 7.2 mg/.75mL; Semaglutide 3.2 mg/mL; Semaglutide 1.7 mg/.75mL; Semaglutide 3 mg/1; Semaglutide 7 mg/1; Semaglutide 14 mg/1
- Dosage forms
- Injection, Solution, Tablet
- Routes
- Subcutaneous, Oral
- Drug classes (FDA established)
- GLP-1 Receptor Agonist
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 29
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|
| Ozempicoral semaglutide | Semaglutide 4 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-1704 | 00169-1704-30 | — |
| Ozempicoral semaglutide | Semaglutide 9 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-1709 | 00169-1709-30 | — |
| Ozempicoral semaglutide | Semaglutide 1.5 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-1715 | 00169-1715-3000169-1715-90 | — |
| Wegovysemaglutide | Semaglutide 1.5 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4415 | 00169-4415-3100169-4415-92 | — |
| Wegovysemaglutide | Semaglutide 25 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4425 | 00169-4425-31 | — |
| Wegovysemaglutide | Semaglutide 4 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4404 | 00169-4404-31 | — |
| Wegovysemaglutide | Semaglutide 9 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4409 | 00169-4409-31 | — |
| Ozempicsemaglutide | Semaglutide .68 mg/mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-8027 | 50090-8027-00 | — |
| Ozempicsemaglutide | Semaglutide .68 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4181 | 00169-4181-1300169-4181-97 | — |
| Ozempicsemaglutide | Semaglutide 2.68 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4772 | 00169-4772-1200169-4772-97 | — |
| Ozempicsemaglutide | Semaglutide 2.68 mg/mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-6051 | 50090-6051-00 | — |
| Wegovysemaglutide | Semaglutide 1 mg/.5mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4501 | 00169-4501-14 | — |
| Wegovysemaglutide | Semaglutide .5 mg/.5mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4505 | 00169-4505-14 | — |
| Wegovysemaglutide | Semaglutide .25 mg/.5mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-5824 | 50090-5824-00 | — |
| Wegovysemaglutide | Semaglutide 2.4 mg/.75mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4524 | 00169-4524-14 | — |
| Wegovysemaglutide | Semaglutide .25 mg/.5mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4525 | 00169-4525-1400169-4525-94 | — |
| Wegovysemaglutide | Semaglutide 7.2 mg/.75mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4572 | 00169-4572-14 | — |
| Wegovysemaglutide | Semaglutide 3.2 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4915 | — | — |
| Wegovysemaglutide | Semaglutide 1.7 mg/.75mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4517 | 00169-4517-14 | — |
| Ozempicsemaglutide | Semaglutide 1.34 mg/mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-5949 | 50090-5949-00 | — |
| Ozempicsemaglutide | Semaglutide 1.34 mg/mL | Injection, SolutionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-4130 | 00169-4130-13 | — |
| Rybelsusoral semaglutide | Semaglutide 3 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4303 | 00169-4303-3000169-4303-99 | — |
| Rybelsusoral semaglutide | Semaglutide 7 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4307 | 00169-4307-30 | — |
| Rybelsusoral semaglutide | Semaglutide 14 mg/1 | TabletOral | Novo Nordisk Pharmaceutical Industries, LP | 0169-4314 | 00169-4314-30 | — |
Semaglutide: common questions
- Which drugs contain Semaglutide?
- Wegovy, Ozempic, Rybelsus.
- Is there a J-code for Semaglutide?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.